Efficacy and Safety of Triple-targeted Drug Therapy in Treatment-naive Patients With Non-low-risk PAH: A Real-world, Multicenter Study
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Observational
SUMMARY
This study is a multicenter, prospective, observational study aimed at investigating the efficacy and safety of triple targeted drug therapy in patients with arterial pulmonary hypertension (PAH) who are not at low risk and are receiving initial treatment. The prognosis of arterial pulmonary hypertension is explored.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 80
Healthy Volunteers: f
View:
• Consent and sign the informed consent form
• Non-low-risk PAH treatment-naive patients
Locations
Other Locations
China
Department of Respiratory, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, #16766, Jingshi Road, Jinan City, Shandong Province, China
RECRUITING
Jinan
Contact Information
Primary
Guanghai Wang, Prof.
224138908@qq.com
+86 18553136966
Time Frame
Start Date: 2024-12-10
Estimated Completion Date: 2027-02-14
Participants
Target number of participants: 48
Treatments
Non-low-risk PAH treatment-naive patients
Related Therapeutic Areas
Sponsors
Collaborators: Chinese Academy of Medical Sciences, Fuwai Hospital, Jianghan University Affiliated Hospital
Leads: Qianfoshan Hospital